Carriers of the apolipoprotein A-I unino (apo A-I M ) variant represent a selected group of subjects showing low levels of high density lipoprotein (HDL), variable hypertrlglycerldemia, and low prevalence of atherosclerotic vascular disease. The distribution of HDL subtractions and the correlation with abnormalities in triglycerlde transport were determined In these subjects. Sera from 24 apo A-I M carriers (A-I H + and from age-and sex-matched normollpldemlc controls (A-I u~) were analyzed by rate zonal ultracentrlrugatlon. The A-I H + subjects showed a marked decrease of HDL 3 mass with reduced flotation rates and major compositional alterations; the HDL 2 were nearly absent The HDL subclasses from 10 A-I u + subjects were resolved according to particle size by gradient gel eiectrophoresis (GGE). The HDL patterns detected In the carriers were unique In exhibiting a distinct peak In the (HDLuJgg, interval, undetectable In the controls. Three patterns reflecting the relative contributions of smaller (HDLjJgg. and larger (HDLj.)™ particles could be distinguished In the carriers, and these were clearly related to different triglycerlde and HDL cholesterol levels in plasma. These findings In a highly selected group of subjects with generally low HDL levels and quite variable triglyceridemia confirmed the existence of relationships between alterations In triglycerlde transport and abnormalities In the HDL subclass distribution, possibly reflecting the variable atherosclerotic risk in hypertrlglycerldemlc subjects. (Arteriosclerosis 7:426-435, July/August 1987)
A negative correlation between plasma high density lipoprotein (HDL) cholesterol level and triglyceridemia has been repeatedly demonstrated in epidemiological studies. 1 This correlation has been proposed as the basis for the association between hypertriglyceridemia and the risk of atherosclerotic vascular disease. 2 On the other hand, few data support a direct connection in selected groups of patients between an altered triglyceride (TG) transport and low HDL cholesterol (HDL-C) levels. ders associated with low HDL levels, 4 such as Tangier and fish-eye diseases, as well as deficiencies of apo A-l-C-lll and of lecithin-cholesterol acyltransferase (LCAT). 5 In some of these disorders, structurally and functionally abnormal HDL particles may account for the extremely variable prevalence of atherosclerotic disease in the affected subjects. 4 A dramatic alteration in HDL apolipoprotein structure concomitant with hypertriglyceridemia has been detected in carriers of the apolipoprotein A -I M ,^ (apo A-I M ) mutant, the first described molecular variant of human apolipoproteins. 6 ' 7 It is characterized by an Arg -> Cys substitution in position 173 of the apo A-l sequence. 8 The presence of a cysteine residue in the variant apolipoprotein allows the formation of complexes with apo A-ll, as well as of apo A-I M , dimers. 7 In the originally identified carrier family, hypertriglyceridemia of variable degree was associated with a marked reduction of HDL-C with levels ranging between 7 and 18 mg/dl. 6 The HDL isolated from these carriers were TG-enriched and cholesteryl ester (CE)-depleted. 9 When pooled HDL from carriers were studied after crosslinking with dimethylsuberimidate, 10 a marked reduction of HDLj and a significant heterogeneity of HDL 3 , characterized by the presence of three different subpopulations, could be detected. More recently, a large group of A-I M + subjects have been uncovered in Limone sul Garda, 11 the village where the origin of the variant gene has been located. A significant elevation of mean plasma TG levels was 426 observed in the A-I M + group, compared to an age-and sex-matched group of controls. This was due in part to a significantly increased prevalence of hypertriglyceridemic subjects among the A-I M + . Both normolipidemic and hypertriglyceridemic A-I M + subjects showed a significant TG enrichment in HDL, associated with a higher phospholipid (PL) and protein content, and with a marked reduction of CE. 12 The A-I M + individuals represent the most numerous known group of subjects carrying an apolipoprotein mutant, while showing a low prevalence of atherosclerotic vascular conditions. 11 In view of the still unclear relationship between HDL subtraction distribution, triglyceridemia, and atherosclerosis risk, 4 the determination of the HDL particle distribution in these subjects is of special interest. The HDL subtractions were resolved by two different techniques: according to lipoprotein flotation rates by rate zonal ultracentrifugation, 13 which separates subfractions by size, shape and density; and according to particle size, by nondenaturing polyacrylamide gradient gel electrophoresis (GGE).
14 It was thus possible to correlate the heterogeneity in the HDL pattern to abnormalities in plasma TG transport in the carriers of the mutant apolipoprotein.
Methods

Subjects
Analyses were carried out in 24 A-I M + subjects (12 females and 12 males, mean age 38.5 ±15.4 years) and 24 sex-and age-matched A-I M~ subjects from the described A-I M kindred.
11 Eight A-I M + subjects were hypertriglyceridemic (HTG), whereas the age-and sex-matched controls were all normolipidemic (NL). 12 Blood was collected after an overnight fast and serum was prepared by low speed centrifugation. EDTA (1 mM final concentration) and solid NaBr were immediately added to raise the nonprotein density to 1.40 g/ml; the sera were stored at 4° C.
Blood from ten A-I M + subjects and from six A-I M~ subjects was also collected into EDTA (1 mg/ml) after an overnight fast; 1.4 mM 5,5'-dithiobis (2-nitrobenzoic acid) was added to plasma, which was immediately shipped on ice to Donner Laboratory, Berkeley, California. The procedures for HDL subfractionation were started within 48 hours after blood collection.
All subjects gave informed consent for the investigations.
along a "blank" gradient was measured at 15° C with an Abbe refractometer.
For apolipoprotein analyses, sera from three A-I M + subjects were fractionated by the classical rate zonal ultracentrifugation (UCF) procedure in a Beckman Ti 14 rotor, as described by Patsch et al. 13 Fractions of 20 ml were collected, concentrated with an Amicon cell equipped with a PM 30 membrane (Amicon Corporation, Danvers, Massachusetts) and were analyzed for lipid and apolipoprotein composition after extensive dialysis against 0.15 M NaCI, 1 mM EDTA (pH 7.4).
Analytic Ultracentrifugation
Analytic ultracentrifugation and computer-derived Schlieren pattern analyses were carried out according to procedures described by Lindgren et al.
17
Gradient Gel Electrophoresls
Ultracentrifugal d < 1.20 g/ml fractions were isolated from plasma and were analyzed by GGE, to determine particle size distribution of HDL. Nondenaturing electrophoresis using precast Pharmacia 4% to 30% slab gels (Pharmacia Fine Chemicals, Piscataway, New Jersey), was employed.
14 The reference proteins used to determine particle diameters were: thyroglobulin, apoferritin, lactate dehydrogenase, and bovine serum albumin. Densitometric scans of gradient gels were obtained with a Transidyne RFT densitometer (Transidyne General Corporation, Ann Arbor, Michigan).
Chemical Analyses
Total and free cholesterol (TC, FC), TG, and PL were determined by enzymatic procedures.
1819 ' 20 CE mass was calculated as (TC-FC) x 1.68.
The protein content of the HDLj and HDL 3 subfractions was evaluated by measuring the absorbances at 280 nm; the extinction coefficients determined in our laboratory for each subtraction were: 0.693 mg protein x A^ for HDL 2 and 0.782 mg protein x A^ for HDL 3 . Protein in the Ti 14 fractions was determined by the method of Lowry et al. 21 Total lipoprotein mass was calculated as the sum of the individual components (FC + CE + PL + TG + P).
Isoelectric focusing (IEF) and SDS-electrophoresIs in polyacrylamide gels were carried out on dellpidated fractions as previously described.
9
Rate Zonal Ultracentrifugation HDL subfractions were routinely isolated by a modification 15 of the rate-zonal density gradient ultracentrifugation procedure described by Groot et al. 16 After a 23-hour run at 40,000 rpm, the gradients were pumped through a Pharmacia (Uppsala, Sweden) UV monitor, and two fractions corresponding to HDL 3 and HDI_2 were collected with a Pharmacia FRAC-100 by pooling all material between the minimal optical density peaks recorded at 280 nm. The elution volume (Ve) of the HDL3 and HDL2 peaks and the total volumes of the two collected fractions were automatically monitored by the FRAC-100. The density profile
Results
Separation of HDL Subfractions by Rate Zonal Ultracentrifugation
Sera from all 48 selected subjects were analyzed by rate zonal ultracentrifugation in an SW 41 rotor. Each ultracentrifugal run processed sera from three A-I M + subjects and from their respective age-and sex-matched A-I M~ controls. Two blank gradients were included every three runs to monitor the density profile of the gradient.
Ultracentrifugation of sera from the control subjects always resulted in a bimodal distribution of the 280 nm absorbance ( Figure 1 and HDLj, were collected; the Ve of the HDL, and HDL 2 peaks ranged between 3.60 and 4.53 ml (mean ± SD 4.03 ± 0.22 ml) and 6.55 to 7.48 ml (mean ± SD7.05 ± 0.18), respectively. When sera from A-I M + subjects were analyzed, a different UV profile was generally observed (Figure 1 ). The HDL3 eluted at a lower volume (range 2.73 to 4.03 ml) with a highly significant difference from A-I M~ in the mean Ve (3.31 ± 0.36 ml; p < 0.001). Furthermore, a distinct HDLj peak was usually absent; in only seven A-I M + subjects (four females and three males) was a rise of the UV absorbance beyond the HDL 3 tail detected. In these cases, the Ve for the apparent peak was in the normal range (6.98 ± 0.25 ml) for HDLj. lntheother17A-l M + subjects, a fraction defined as "HDL2" was collected between the end of the HDL 3 tail and the beginning of the low density lipoprotein (LDL) + very low density lipoprotein (VLDL) elution.
Slower floating HDL 3 particles could be detected In the 8 HTG A-I M + subjects (Ve = 3.21 ± 0.34 ml), compared to NL A-I M + (Ve = 3.42 ± 0.22 ml), whereas no differences were observed in HDL 2 , a relatively distinct HDL 2 peak being detectable in three HTG and four NL A-I M + subjects. The A-I M + subjects showed a marked reduction of both HDL 2 and HDL 3 when compared to A-I M~ in terms of associated TC and total lipoprotein mass ( Table 1 ). This was particularly true for the HDL 2 subtraction, the HDLj/HDLg ratio being significantly lower in the A-I M + subjects compared to the controls, both for TC (0.200 ± 0.069 vs. 0.435 ± 0.281; p < 0.005) and for lipoprotein mass (0.195 ± 0.064 vs. 0.337 ± 0.212; p < 0.005). The HTG A-I M + subjects showed slightly lower TC levels compared to NL A-I M + subjects, both in HDL 2 (3.0 ± 1.6 vs. 3.3 ± 1.9 mg/dl) and in HDL 3 (14.7 ± 6.1 vs. 16.7 ± 6.7 mg/dl), whereas the lipoprotein masses and ratios were identical in the two groups. In the controls, but not in the A-I M + subjects, a significant difference could be detected in the HDLj levels between males and females ( Table 1) .
The composition of the HDL subtractions was markedly different in the A-I M + subjects compared to A-I M~ subjects; both HDL 2 and HDL 3 were TG-and protein-enriched but poor in CE (Table 2) . In all the A-I M + subjects, the composition of HDL 2 was very similar to that of HDL 3 , thus confirming that in most of these subjects, an HDL 2 subtraction of clearly defined morphology and composition cannot be isolated.
To analyze the apolipoprotein composition of different lipoproteins in the HDL density range, sera from three NL A-I M + subjects were subjected to UCF in a zonal T114 rotor. The material eluting in the HDL region was subdivided into 20 ml fractions and then analyzed for lipid and apolipoprotein composition ( Figure 2 ). There were no significant variations in the lipid composition of particles eluting at different densities (data not shown).
The distribution of the three major A-l isoproteins along the elution profile of zonal UCF did not vary markedly All values represent the mean ± SD. "HDL 2 " identifies a fraction collected between the end of the HDL 3 tall and the beginning of the LDL + VLDL elution in the 17 A-I M + subjects who did not show a distinct HDL, peak. HDL = high density llpoprotein. (Table 3 ). However, a slightly higher content of apo A-l-1, previously identified as a normal apo A-I in the A-I M + subjects, 8 was noted in the ascending portion of the HDL 3 peak (fractions M through P), corresponding to HDL 3 
Resolution and Identification of HDL Subclasses by Gradient Gel Electrophoresis
Densitometric patterns of Coomassie-stained GGE gels of the ultracentrifugal d < 1.20 g/ml fractions isolated from plasma of six A-I M~ and ten A-I M + subjects are shown in Figures 3 and 4 . The particle size intervals of the major HDL subpopulations encountered in normal plasma are indicated under each of the GGE patterns. These subpopulations have been previously described according to their relationship to the major uitracentrifugal HDL subclasses: 14 HDL patterns of A-I M + subjects were characterized by major peaks with maxima primarily within the particle size intervals of (HDLa)^ subpopulations, namely the and (HDL^ggg. Peaks with maxima in the gg interval, which in normal subjects contains the major HDLj subclass, were either minor or nondetectable. Compared to patterns of A-I M~ HDL, A-I M + HDL were unique in consistently exhibiting a distinct peak within the (HDL^gge interval.
The mean particle sizes of the major components with peak maxima in the (HDL 3a ) Bg<) and ( H O L^)^ intervals in A-I M + (8.6 ± O.f and 8.0 ± 0.03 nm, respectively) were almost identical to those in A-I M~ (8.4 ± 0.07 and 7.9 ± 0.02 nm, respectively). The mean particle size of the major component in the (HDLa,)^,, interval was, however, significantly smaller (9.9 ± 0.2 vs. 10.3 ± 0.3 nm) in the A-I M + compared with that in the A-I M~. Thus, the particle sizes of the major HDL 3 subpopulations in subjects with the apo A-I M variant were not significantly different from sizes of their counterparts in control subjects.
HDL isolated from the ten A-I M + subjects showed three characteristic patterns (I, II, and III, Figure 4) , reflecting the relative contributions of the two major peaks. Pattern I was characterized by a predominant peak in the (HDL^gg,, interval, together with a peak of lower amplitude in an interval which includes both (HDLzJgg,, and (HDLgJgg,,, [(HDL^+aJggJ. In Pattern II, the two peaks were located within approximately the same particle size intervals as in Pattern I but now were of comparable amplitude. Pattern III was identified by a markedly increased amplitude of the peak in the (HDLja+aJgge interval, together with a distinct peak in the (HDLjbJgg,, interval, as in Patterns I and II.
The group of A-I M + with pattern I exhibited the lowest mean HDL-C value (9.3 ± 1 . 5 mg/dl) compared with that of A-I M + with Patterns II and III (II: 14.6 ± 4.6 mg/dl; III: 28.0 ± 9.9 mg/dl). Thus, at reduced HDL-C levels, the particle size pattern became relatively enriched in the smaller HDL subpopulations. Progressive, relative enrichment of HDL patterns with species of smaller particle size as a function of decreasing plasma concentration of HDL-C has also been observed in normal subjects from other populations. 22 For normal male adults (age range 35 to 59 years, n = 91), the correlation coefficient relating the percent of the total HDL pattern in the particle size interval of the small subpopulation (HOL^),,^ vs. HDL-C was -0.79 (p < 0.001 ). 22 The correlation coefficient between the same parameters for the small sample of ten A-I M + subjects was -0.90 (p < 0.001). The mean HDL-C plasma level in the above ten A-I M + subjects was 15.7 ± 8.3 mg/dl, while the mean level in the 91 normal male subjects was 44.0 ± 1 1 . 6 mg/dl.
HDL Subpopulations and Plasma Llplds
It is well established that low levels of HDL-C are frequently observed in association with elevated plasma TG levels and this also appeared to be the case for A-I M + . Thus, for 29 A-I M + subjects, 12 the correlation coefficient for plasma TG level vs. HDL-C was -0.35 (p < 0.05); for the 91 normal males cited above, the correlation coefficient for the same variables was -0 . 4 9 (p < 0.001). When values of plasma TG and HDL-C were plotted for ten A-I M + and six A-I M " subjects whose HDL were analyzed by electrophoresis, the group of A-I M + subjects with Pattern I exhibited the lowest mean HDL-C value and the highest mean TG value, relative to those of A-I M + subjects with Patterns II and III ( Figure 5 pertriglyceridemia (222 to 2,500 mg/dl) and reduced HDL-C levels (22 to 30 mg/dl) has been previously reported by Eisenberg et al. 23 Pattern II, with (HDLj^gg,, and ( H O L^^g^ peaks of similar amplitude, was associated with normal triglyceridemia as well as low HDL. Finally, Pattern III, with a markedly increased amplitude of the (HDL^+^gg,, peak, appeared in only two subjects, a male 37 years old actively engaged in marathon running, and a female 66 years old. These two subjects showed normal triglyceridemia and HDL-C levels in the range of 20 to 40 mg/dl.
Analytic Ultracentrlfugatlon
Analytic ultracentrifugal patterns of HDL from six A-I M + subjects, whose plasma levels of HDL-C ranged from 8 to 35 mg/dl, are shown in Figure 6 . The total plasma HDL of this group of A-I M + subjects ranged from 19.5 to 261.5 mg/dl and showed a predominance of HDL 3 as gauged by the pattern area within the flotation interval of P, x 0 to 3.5. HDL material in the flotation interval of P 1-20 3.5 to 9.0 corresponding to the HDL 2 subclass was observed in A-I M + subjects at the higher plasma HDL-C levels. Plasma concentrations of HDLj in these subjects ranged from 0 to 55 mg/dl. At the higher levels of HDL-C, the flotation rate of the major HDL Schlieren peak was also shifted to higher values, consistent with the presence of the additional faster floating HDL 2 species. Analytic ultracentrifugal patterns of HDL (not shown) from the four A-I M~ subjects with HDL-C and total plasma HDL levels ranging between 42 and 76 mg/dl and 201 and 309 mg/dl, respectively, gener- ally showed HDL3 levels higher (164 to 214 mg/dl) than those in A-I M + subjects (25 to 183 mg/dl); the range of HDLz in A-I M " subjects was 4 to 133 mg/dl. The analytic ultracentrifugal results were consistent with the rate zonal ultracentrifugal data.
Discussion
The isolation and characterization of HDL from a group of carriers of the apo A-I M variant and from age-and sexmatched controls was achieved by two different techniques. Both rate zonal UCF and GGE confirmed the marked reduction of HDLj in the carriers previously detected by cross-linking studies. 10 Peaks with maxima in the HDLj region were undetectable in 17 out of the 24 A-I M + subjects analyzed by zonal UCF and in six out of 10 A-I M + subjects tested by GGE. Furthermore, the HDLj present in the A-I M + subjects differed from control HDLj particles in both composition and size.
Reduced HDL 2 levels have been detected in atherosclerotic patients 24 and in hypertriglyceridemic subjects. 23 The former observation led to the suggestion that HDL 2 might be responsible for the protective effect of HDL against atherosclerosis. 25 The A-I M + subjects, in spite of the markedly reduced levels of HDL, did not suffer from premature cardiovascular disorders. 11 In hypertriglyceridemic subjects, the decreased HDL 2 levels are probably related to the reduced breakdown of TG-rich lipoprotein particles, which normally supply surface material for the direct production of HDL 2 and/or for the conversion of HDL 3 to HDLz. 26 As a group, the A-I M + subjects showed increased plasma TG levels 11 and generally developed hypertriglyceridemia with aging: the catabolism of TG-rich lipoproteins is, however, apparently normal in these subjects. 6 Although it cannot be excluded that the apparent absence of HDLj in the A-I M + subjects is simply a reflection of the low mass of total HDL, 17 it may be noted that no correlation between HDL 2 and total HDL levels could be detected In the A-I M + subjects; furthermore, in the A-I M + females, who showed higher total HDL concentrations compared to male carriers, 11 the HDL2/HDL 3 ratio was similar to that recorded in the A-I M + males. Partial conversion of HDL3 into HDLz-like particles occurs in vitro by the uptake of lipids (PL and FC) and apolipoproteins (particularly apo C) released from the surface of lipolysed VLDL. 28 This process, apparently saturable for lipids and apolipoprotelns, is not, however, sufficient for the conversion of HDL, to HDLj. Conversion to HDL 2 would probably require cholesterol esterification for further core build-up and some remodeling of lipid and apolipoprotein composition. 27 In the A-I M + subjects, LCAT activity is reduced compared to normal subjects 12 which probably contributes to the increased FC/CE ratio in plasma and particularly in HDL 3 and may hinder conversion to HDL 2 . Furthermore, the presence of large apolipoprotein complexes, apo A-IM-A-II and apo A-IM-A-IM, on the surface of HDL may impair remodeling and transfer of apolipoprotein molecules from one particle to another. 28 Previous studies of hypertriglyceridemic subjects by rate zonal UCF showed that, in the presence of low HDL levels, slower floating HDL 3 , also called HDLao, may be the only HDL population. 13 Similarly, in patients with severe hypertriglyceridemia due to apo C-ll deficiency, 29 only very dense, CE-poor and TG-rich HDLj can be detected. The studies with A-I M + subjects provided an unusual occasion to examine subjects with generally very low HDL levels but with quite variable triglyceridemia. In HTG A-I M + subjects, HDLj of significantly different structure and composition could be detected, compared to NL A-I M + . These particles have a lower flotation rate, are richer in TG, and show a higher FC/CE ratio. These data confirm previous observations 13 ' a on the crucial effect of plasma TG levels on the distribution of HDL subclasses in humans.
The GGE studies provided a better differentiation between NL and HTG A-I M + subjects based on the HDL 3 subtraction pattern. The HDL 3 particle distribution in all analyzed A-I M + subjects differed significantly from that of normal subjects, the major modification being the presence of a distinct peak in the (HDLaOg,,, interval that was undetectable in controls. The observation of three different patterns, I, II, and III (Figures 4 and 5) , indicates that the relative amount of the small (HDLjbJgg,, particles in the A-I M + subjects is mainly determined by the plasma TG levels, and possibly reflects total HDL in plasma.
Distinct peaks in the small HDL particle size intervals have been detected in several lipoprotein disorders, i.e., hypertriglyceridemia, 14 LCAT deficiency, 30 fish-eye disease, 31 apo A-r-C-lll deficiency, 32 and in human cord blood. 33 All these conditions differ from the A-I M + by the presence of larger (HDLaJgg, particles and/or even smaller (HDLjcJgg. particles. The large HDL detected in apo A -l -C-lll and LCAT deficiencies, as well as in human cord blood, contain apo E mainly in the form of apo E-A-ll complex as a major protein constituent. 30 ' x -M These particles can accumulate in plasma reflecting a slow catabolism, due to the inability of the apo E-A-ll complex to interact with apo B,E receptors. 34 The smaller (HDLjJgg,,, detected in fish-eye disease 31 may represent unreacted precursors of normal HDL. 35 Small, spherical HDL, similar to those secreted by the intestine, 38 have also been detected in subjects with LCAT deficiency. 37 On the other hand, in vitro studies on normal plasma incubated with mercaptoethanol, which stimulates LCAT activity, showed simultaneous conversion of (HDLaJgg,, and (HDLyJgg, to larger subpopulations and to particles in the ( H D I^.^ interval. 38 Hepatic lipase is also known to participate in the formation of small HDL3 particles both in vitro 39 and in vivo 40 through the hydrolysis of the TG core of large, TG-rich HDLj particles.
The origin of the (HDL^Jgg, particles and their relationship to hypertriglyceridemia is less clear. Such particles may be present in HTG subjects with relatively normal HDL levels 14 and with very low HDL levels, as in fish-eye disease, 31 LCAT deficiency, 30 and in the A-I M + subjects. On the other hand, distinct (HDL^gg, peaks have been detected in human cord blood 33 and in apo A-l-C-lll deficiency, 32 conditions associated with low plasma TG levels. In the A-I M + subjects, the reduced LCAT activity, which is directly correlated to the total HDL mass, 12 may play a role in the formation of the anomalous HDL particles. The hypertriglyceridemia, which is apparently related to the amount of the mutant apolipoprotein 9 and not inherited as a separate disorder," can also modify the normal conversion of HDL particles in the plasma. In vitro studies on the incubation of A-I M + plasma, both in the presence and absence of active LCAT, are in progress in order to gain more information on the possible origin of the A-I M + HDL particles. It should also be underlined that the need for HDL particles in the A-I M + subjects to accommodate large apolipoprotein complexes on their surface, such as apo A-IM-A-I M and A-IM-A-II, may markedly modify the physical properties of these lipoproteins. In particular, HDL 3 floating in the usual density region, appear to be rich in normal A-l, thus possibly representing normal HDL, particles corresponding to the (HDLsJgg, subpopulation detected in the plasma of the A-I M + subjects. Slower floating and denser HDL appear to be enriched in the apo A-IM-A-II complex corresponding to the anomalous lipoproteins migrating in the (HDLa,)^,, interval.
The occurrence of hypertriglyceridemia in the A-I M + individuals may be due to the presence of HDL particles which contain only the apo A-ly-A-ll complex, and hence are inactive substrates for the LCAT reaction. 41 The correlation between the relative (HDLgtJgge content and triglyceridemia in the A-I M + supports this hypothesis. Reduced levels of acceptors of surface material from VLDL lipolysis may lead to the accumulation of TG-rich lipoproteins in plasma. With reduced CE formation, combined with a marked decrease of the plasma pool of normal HDL, the transfer of CE to VLDL may also be impaired. 42 The exchange of CE and TG will occur predominantly between VLDL and LDL, 43 with consequent formation of TG-rich and CE-poor LDL in plasma. 12 By these mechanisms, A-I M + subjects with HTG may represent the final result of a series of events where a progressive derangement of the complex pathways regulating the interaction between HDL and TG-rich lipoproteins may take place accounting for the appearance of hypertriglyceridemia in the older A-I M + subjects.
11
